Risk Factors and Predictive Model for Disseminated Intravascular Coagulation in Patients with Multiple Myeloma
Objectives Multiple myeloma (MM) is a hematologic malignancy comprising approximately 10% of all blood cancers. Patients with MM are at risk for disseminated intravascular coagulation (DIC), a serious complication characterized by systemic coagulation activation, leading to microthrombi, organ dysfu...
Saved in:
Main Authors: | Rong Bao MM, Mengtong Fan MM, Min Hu MM, Ling Li BD, Hasichaolu BD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296251316873 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the epidemiology of disseminated intravascular coagulation: protocol for the DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study
by: Henrik Toft Sørensen, et al.
Published: (2022-07-01) -
Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma
by: Jeremy Chuang, et al.
Published: (2019-01-01) -
Disseminated Intravascular Coagulation and Malignancy: A Case Report and Literature Review
by: Sumit Sohal, et al.
Published: (2020-01-01) -
Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
by: Shawn Y. Ong, et al.
Published: (2015-01-01) -
Exploring the Mediating Role of Multiple Organ Dysfunction in Sepsis-Induced Disseminated Intravascular Coagulation and Its Impact on Worsening Prognosis
by: Guangjie Wang MD, et al.
Published: (2024-08-01)